| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be944a7839fc8cabe752928d03dafaa4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-01 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0278
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 |
| filingDate |
1995-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ea965b21babf6974a48378a9bf4a3ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b19872e651da9304182f450454e27df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a37b00a1bdb581875fa80b272b195e40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea77f866c0bea07555c05b384339477e |
| publicationDate |
1998-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5814716-A |
| titleOfInvention |
Cell lines from a transgenic mouse which express biologically active IX factor |
| abstract |
Cell lines have been prepared from transgenic mice comprised of a first exogenous DNA sequence encoding human factor IX which is controlled by a promoter region specific for hepatic cells and a second exogenous DNA sequence encoding an oncogene, such as the SV40 virus gene encoding the T-antigen or the mouse c-myc gene, which is controlled by a promoter region specific for hepatic cells. Promoter regions specific for hepatic cells included the promoter region for the factor IX gene and the promoter region for the alpha -1 antitrypsin gene. The cultured cells produce biologically active human factor IX which is then isolated from the culture media. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004038898-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7125841-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0075279-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011015656-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3626832-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013045668-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013045658-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3587455-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7341871-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006031956-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0075279-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1581614-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1925626-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014066443-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016085876-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016086197-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004110675-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013007772-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6740519-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1944318-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1581614-A2 |
| priorityDate |
1989-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |